HOME >> BIOLOGY >> NEWS
Conference to address the challenge of renewable resources

A major international conference focusing on the growing impact of Renewable Resources will take place at the University of York, in the UK, next September.

The three-day symposium, which starts on 6 September 2006, will bring together academics, industrialists and policy-makers to discuss the challenges the world faces in embracing renewable resources - and present novel developments in their use.

The event at York will build on the success of the inaugural Renewable Resources and Biorefineries Conference hosted by the University of Ghent in Belgium on 19-21 September 2005, that attracted 330 delegates from 28 countries including Dr Christian Patermann, EU Director for Biotech, Agriculture and Food Research, representatives from the US Dept of Agriculture and from all levels of national governments.

As a Science City and with a University that is a centre for world-class research in Biotechnology and Green Chemistry, York is the ideal venue to host the second of these events.

Featuring a series of keynote speakers, the York conference will also include plenary lectures, oral presentations and an exhibition of scientific equipment and services.

The conference will highlight a range of topics including:

  • European Policy and Socio-Economic Issues
  • Biorefineries
  • Renewable Feedstocks for chemical manufacture
  • Industrial biotechnology and bioprocessing
  • Carbohydrates and Oleochemicals
  • New Materials and Products based on Renewable Resources
  • Biofuels and Bio-energy
  • Sustainability of the use of renewable resources
  • Investment

    Professor James Clark, of the York event's organising committee, said: "The inaugural conference in Ghent was inspirational and we want to build on its tremendous success."

    Details of how to reserve places at the symposium will be announced early in the New Year.


    '"/>



  • Contact: David Garner
    dcg501@york.ac.uk
    44-190-443-2153
    University of York
    19-Dec-2005


    Page: 1

    Related biology news :

    1. National Ecological Observatory Network featured at ESA/SER Joint International Conference
    2. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
    3. Naval Science and Technology Conference 2007
    4. Scientists to make news at Computational Biology Conference
    5. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
    6. Journalists can register now for ECCO 14 -- the European Cancer Conference
    7. Global community listens to TAU genetic researcher at EU Conference on Hearing Loss
    8. Conference to examine role technology can play in managing health care costs
    9. Energy 2100 Conference rescheduled to Fall 2007
    10. ANA 2007 Quadrennial Policy Conference
    11. Clinical trial data regarding NKTR-061 will be presented at ATS International Conference

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    TAG: Conference address the challenge renewable resources

    (Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
    (Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
    (Date:6/24/2015)... June 24, 2015 This report provides market ... next six years. It contains an analysis of the ... with their impact from the short, medium, and long ... the industry, market, and technology trends that currently, prevail ... of concerned authorities to efficiently manage the increasing marine ...
    Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4TAKE Solutions Awarded Patent By USPTO 2Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
    (Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... designer, manufacturer and supplier, announces the launch of their 2nd generation cell therapy ... the current miniPOD CT, but it also represents a new POD® design. ...
    (Date:7/29/2015)... 2015  AmnioChor Inc., an early stage biotech startup ... to announce that the Musculoskeletal Transplant Foundation of ... in their seed round of development of the proprietary ... AmnioChor,s technology allows cryopreservation of the ... cells living within those tissues. Amnion is a well-established ...
    (Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
    (Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
    Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
    Cached News: